Vaccine misinformation blamed for fatal CDC shooting
The alleged shooter, Patrick White, died of a self-inflicted gunshot wound. Authorities said they found documentation in his house expressing his discontent with the COVID-19 vaccinations.
Chris Hosey, director of the Georgia Bureau of Investigation, said the content of the documents was more about making the public aware of his distrust of the vaccine, though no direct threats were made.
The American Federation of Government Employees (AFGE) union called out vaccine misinformation for putting agency staffers at risk. In a statement following the shooting, AFGE Local 2884 demanded a 'clear and unequivocal stance in condemning vaccine disinformation by CDC and HHS leadership.'
'Their leadership is critical in reinforcing public trust and ensuring that accurate, science-based information prevails. This condemnation is necessary to help prevent violence against scientists that may be incited by such disinformation,' the organization said.
Former U.S. Surgeon General Jerome Adams, who served during President Trump's first term, echoed these sentiments. In an op-ed for Stat, Adams said the shooting was a reflection of threats to public health workers brought on by a climate of 'misinformation, politicization, and inflammatory rhetoric.'
Health Secretary Robert F. Kennedy Jr., who Adams criticized for being slow to respond to the shooting, was not named by the AFGE, but has long spread vaccine misinformation.
During an interview with Scripps News this week, he defended his decision to end funding for mRNA shots and reiterated his concerns about coronavirus vaccine injuries.
When asked directly about a plan to quell misinformation and prevent something like the CDC shooting from happening again, Kennedy deflected any direct link.
'We don't know enough about what the motive was of this individual, but people can ask questions without being penalized,' Kennedy said, before criticizing the federal government's messaging about the coronavirus vaccine.
Kennedy previously criticized CDC during his unsuccessful presidential campaign, calling it a 'cesspool of corruption' in a post on X, saying he would 'force the public health agencies to come clean about Covid vaccines.'
During his Scripps interview, Kennedy sounded a different tone.
'They work in silence, saving us all and protecting our health. They should not be the targets of this kind of violence from anybody,' Kennedy said.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
41 minutes ago
- The Hill
FDA may pull authorization for Pfizer COVID shot for kids under 5
The Food and Drug Administration (FDA) is considering revoking the authorization of Pfizer's COVID-19 vaccine for healthy children under 5 years old, the company confirmed Wednesday. The move would add another barrier for parents who want to vaccinate healthy children, as shots from Moderna and Novavax were approved for more limited populations. In May, Health and Human Services Secretary Robert F. Kennedy Jr. said that the Centers for Disease Control and Prevention (CDC) would no longer recommend COVID-19 vaccines for healthy children or pregnant women. The CDC then updated its immunization schedule to reflect that children with no underlying health condition 'may receive' COVID-19 vaccines after consulting with a health care provider — what's known as 'shared decision-making.' If FDA pulls its emergency use authorization, Pfizer's vaccine would no longer be available to any children younger than 5. Right now, Moderna and Novavax shots could be administered 'off label' to healthy children. 'We are currently in discussions with the agency on potential paths forward and have requested that the EUA for this age group remain in place for the 2025-2026 season,' a Pfizer spokesman told The Hill. 'It is important to note that these deliberations are not related to the safety and efficacy of the vaccine which continues to demonstrate a favorable profile,' the company added. The Guardian first reported on the FDA's potential move. In a statement to The Hill, HHS said it wouldn't comment on potential changes. 'The COVID-19 pandemic ended with the expiration of the federal public health emergency in May 2023. We do not comment on potential, future regulatory changes. Unless officially announced by HHS, discussion about future agency action should be regarded as pure speculation,' HHS spokesman Andrew Nixon said. Pfizer has had full FDA approval for its COVID-19 vaccine for individuals age 12 and older since 2022.
New York Post
41 minutes ago
- New York Post
CDC shooter Patrick Joseph White's dad repeatedly called 911 fearing he was gunman
The father of the anti-vaxxer gunman who killed a cop when he fired more than 180 shots at the US Centers for Disease Control and Prevention repeatedly called 911 fearing that his son was responsible for the attack, newly released 911 calls show. Kenneth White had begged authorities for help as his son, Patrick Joseph White, was unleashing his reign of terror on the CDC's Atlanta headquarters last Friday, according to transcripts obtained by 11Alive. 'I'm very worried that he might have been involved in this shooting today,' the dad said in one call. Advertisement 3 Documents found in a search of the home where CDC shooter Patrick Joseph Smith lived with his parents revealed his discontent with the COVID-19 vaccinations. AP 'I can't get any information from anybody. I've called the DeKalb County 911 number three times and left detailed information, and no one ever called us back. I don't know if he was involved. I need some help.' In another call, the dad specifically asked for one officer to call back given he'd helped with his son in the past. Advertisement 'He has been involved last summer with some problems we had with my adult son,' the elder White said of the cop. '[The officer] had left me his name and number and said if you guys need anything with Patrick, give me a call.' Records show there had been at least 10 emergency calls made from the White family home over the last two years, including for suicide threats and domestic disturbances. 3 Patrick Joseph Smith fired more than 180 shots into the CDC campus in Atlanta and broke 150 windows on Friday. AP It wasn't immediately clear if authorities returned the calls from White's dad during Friday's incident. Advertisement The shooter, who authorities said blamed the COVID-19 vaccine for making him depressed and suicidal, was found dead from a self-inflicted gunshot wound shortly after his rampage. Investigators said White had broken into a locked safe to get his father's weapons before he stormed the CDC's headquarters. CDC security guards had initially stopped White from driving into the campus Friday — so he parked near a pharmacy across the street and opened fire from the sidewalk, authorities said. 3 Police vehicles near Emory University and the CDC campus in Atlanta after the shooting on Aug. 8, 2025. Getty Images Advertisement His bullets broke about 150 'blast-resistant' windows across the campus. DeKalb County Police Officer David Rose was fatally shot while responding to the rampage, according to investigators. No one inside the CDC building was injured. In the aftermath, a search warrant at White's home uncovered a slew of written documents and electronic devices that are still being analyzed. Some of the materials 'expressed the shooter's discontent with the COVID-19 vaccinations' and his desire to make 'the public aware of his discontent with the vaccine,' Georgia Bureau of Investigation Director Chris Hosey said. With Post wires
Forbes
42 minutes ago
- Forbes
InnovationRx: Shooting At The CDC Highlights The Perils Of Health Misinformation
In this week's edition of InnovationRx, we look at the shooting at the CDC, longevity drugs for dogs (and maybe eventually people too), Strand Therapeutics' programmable mRNA for fighting cancer, Tahoe Therapeutics' AI models of living cells, and more. To get it in your inbox, subscribe here. CDC's Atlanta campus getty On Friday evening, a 30-year-old man who believed the COVID-19 vaccine had made him ill fired hundreds of bullets on the Centers for Disease Control and Prevention's Atlanta headquarters. A DeKalb County police officer was killed in the attack. The shooting followed years of conspiracy theories and misinformation about vaccines. Christa Capazzola, the CDC's acting chief operating officer, called the shooting 'a targeted attack on CDC related to COVID' in a Saturday email addressed to the agency's employees. A union representing CDC workers called on federal officials to condemn misinformation about vaccines. Attacks on science have increased since President Trump took office in January, and his HHS Secretary Robert F. Kennedy Jr. has sought to blame the CDC for the pandemic. In 2021, he falsely called the COVID shots the 'deadliest vaccine ever made.' Then, last week, the Trump Administration canceled almost $500 million in contracts to develop mRNA vaccines that could protect against future infectious disease outbreaks or pandemics to the horror of public health experts. On Saturday, the day after the shooting, National Institutes of Health director Jay Bhattacharya appeared on Steve Bannon's 'War Room' podcast to claim that the public didn't trust mRNA technology—without commenting on the role he or his boss played in that. On a call with the staff of the National Center for Immunization and Respiratory Diseases, CDC employees recounted harrowing experiences during the shooting and asked about the misinformation that may have influenced the shooter, according to reporting by Stat. One employee, struggling to hold back tears, said that she had been sheltering in place during the attack and didn't feel safe until she saw the SWAT team. 'So I think it would be helpful to know what went right so that we feel like we weren't just sitting ducks,' she said. Startup Loyal Is Working On A Longevity Pill For Dogs – And Maybe Someday For Humans, Too Loyal's Celine Halioua Ethan Pines for Forbes D ogs don't live long enough. Celine Halioua – an Oxford Ph.D. dropout and former chief of staff at the first venture capital fund focused on longevity-related biotechs – thinks they deserve a few more years. She's spent the last nearly six years building Loyal, a San Francisco startup developing drugs to delay canine aging by targeting metabolic and hormonal imbalances before they become disease. The company's first beef-flavored longevity pill could hit the market by 2026, potentially extending dogs' lives–and perhaps someday ours as well. 'I realized that to do this in humans would take billions of dollars, patent issues and trauma, but you could do it in dogs,' says Halioua, 30, whose own dog, Della, is a senior Rottweiler mix that she adopted three years ago. Loyal doesn't have any revenue yet, but Halioua is in conversations with the FDA and has cleared early hurdles. Under the agency's conditional approval program for innovative veterinary drugs, Halioua hopes to get the okay to be on the market with its first drug, which changes the metabolism of senior dogs (ages 10 and up) to mimic a low-calorie diet, which has been shown to extend their lives, next year. Loyal also has both a shot and a pill in the works to lengthen large dogs' short lifespans by limiting a growth hormone more prevalent in big dogs than small. Halioua has raised $135 million equity from top investors that include Bain Capital, First Round, Khosla Ventures and Valor Equity Partners at a valuation of $425 million. The market is potentially enormous: There are nearly 90 million dogs across some 60 million households in the United States, according to the American Veterinary Medical Association. Last year those households spent an average of $1,852 on their pups, a 6% increase over 2023. Loyal's drugs have the potential to quickly generate hundreds of millions in revenue, should they get the regulatory nod. Beyond that, Loyal hopes that its success with dogs will someday open an even bigger market: people. That's a herculean task given the cost and time it might take to develop a human longevity drug and get it approved. But Halioua thinks the science will ultimately win out. 'I think the general public will be blown away when they realize they can go to the vet and get a drug to extend their dogs' lifespan,' she says. 'Then they'll get like, 'Why can't I do this for my grandma?'' Read more here. BIOTECH AND PHARMA Strand Therapeutics raised $153 million led by Swedish investment giant Kinnevik to make cancerous tumors light up, making them reveal themselves to the body's immune system. The deal, at an estimated $550 million valuation, followed early clinical results showing its programmable mRNA shrank patients' tumors who were out of other treatment options. 'It shocked even us,' Strand cofounder and CEO Jake Becraft told Forbes. Read the whole story here. DIGITAL HEALTH AND AI One of the holy grails of biology is digitally simulating a living cell. If researchers can use computers to more accurately understand how new medicines would react in the body, that could give them greater confidence when they're tested on animals and humans. But the missing piece of making this a reality is data. Tahoe Therapeutics got one step closer to that goal with the February release of Tahoe-100M, a collection of 100 million different datapoints showing how different kinds of cancer cells responded to interactions with more than 1,000 different molecules. This type of data is crucial to training AI models, because information on how cells respond to various molecules improves an algorithm's ability to predict how they'll be affected by others. This week, Tahoe announced $30 million in new venture funding, led by Amplify Partners, bringing the company's total funding to $42 million and its valuation to $120 million. 'Our core superpower is the ability to generate the massive datasets required for virtual cell models,' CEO Nima Alidoust told Forbes. Read the whole story here. PUBLIC HEALTH AND HOSPITALS Annals of Internal Medicine published a large-scale study of more than 1.2 million children over the course of 23 years to determine if aluminum in vaccines is related to any chronic disorders in July. The study found no evidence of such a link, highlighting both the safety and effectiveness of childhood vaccines. HHS Secretary Kennedy critiqued the study's methodology and demanded its retraction, something that the journal refused to do. The publication Unbiased Science, written by public health scientists, has an excellent breakdown of the study and explains why Kennedy's critique is flawed. Plus : A preliminary study suggests that bird flu (H5N1) may be airborne on dairy farms. NEXT BILLION-DOLLAR STARTUPS Twenty of the 25 companies on this year's Forbes' Next Billion-Dollar Startups list of VC-backed startups we think most likely to become worth $1 billion or more are focused on artificial intelligence. Three of them–Collate, Assort Health and AcuityMD–use AI to improve operations in healthcare. Assort Health sells a text-to-voice artificial intelligence chatbot to search physicians' calendars to match their openings with the type of appointment required, cutting wait times on millions of inbound calls to medical groups. Acuity MD uses AI to sift through de-identified records, helping medical device manufacturers connect to physicians whose patients might benefit from different products. And Collate, which came out of stealth in January, uses AI to automate the paperwork required for life sciences companies, such as that for clinical trials and FDA approval. 'This stuff they would have spent months doing we can do over the course of days,' says cofounder and CEO Surbhi Sarna. See the full 2025 list here. WHAT WE'RE READING Trump delayed a change on Medicare's coverage of pricey bandages after a health company that makes them donated millions to political action committee MAGA, Inc. As GLP-1 drugs shrink appetites, some restaurants are offering miniature meals and tiny tasting menus. Eli Lilly's much-anticipated obesity pill, called orforglipron, fell short of Zepbound and Wegovy, leading to 11% weight loss in a late-stage clinical trial. The company's stock plummeted on the news and hadn't recovered as of Tuesday's market close. Why Trump's firing of the Bureau of Labor Statistics commissioner also puts crucial health data at risk. A new study published this week found encouraging early results for a cancer vaccine in patients with pancreatic and colorectal cancer, two indications that are difficult to treat. AbbVie plans to spend $195 million on a facility to manufacture active pharmaceutical ingredients at its campus north of Chicago. The FDA approved Boehringer Ingelheim's zongertinib, an oral lung cancer treatment for patients with HER2 mutations. MORE FROM FORBES Forbes How AI Data Centers Could Save California's High-Speed Rail Project Forbes Inside The Richest Presidential Cabinet Ever Forbes Zuckerberg Squandered His AI Talent. Now He's Spending Billions To Replace It.
